ARTICLE | Company News
Aronex, Sumitomo deal
January 2, 2001 8:00 AM UTC
In a deal that resolves a U.S. patent interference proceeding regarding the use of Aroplatin, ARNX obtained an exclusive license from Sumitomo to one class of DACH (diaminocyclohexane) platinum compo...